Health Condition 1: H65-H75- Diseases of middle ear and mastoid Health Condition 2: H758- Other specified disorders of middle ear and mastoid in diseases classified elsewhere Health Condition 3: H729- Unspecified perforation of tympanic membrane
Conditions
Interventions
Intervention1: ESMOLOL: Group I – Titrated dose of I.V. Esmolol infusion to maintain MAP 60-65mm of Hg
Group II – Titrated dose of I.V. Nitroglycerine infusion to maintain MAP 60-65 mm of Hg
Contro
Sponsors
Kalinga Institute Of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.American society of Anesthesiologist (ASA) I and II 2.Elective middle ear surgery under General Anaesthesia
Exclusion criteria
Exclusion criteria: 1.patient on anti platelet therapy 2.history of coagulation and bleeding disorder 3.BP more than 140/90mm Hg 4.heart rate more than 120bpm and less than 60bpm 5.heart block, reactive airway disease, CHF, vascular disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| quality of bloodless surgical field. The surgical site is assessed by 6 point Fromme et. al. Timepoint: intra operative period after the use of microscope in the interval every 5 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| heart rate, mean arterial pressureTimepoint: intra operative period after the use of microscope in the interval of every 5 minutes | — |
Countries
India
Contacts
Public ContactMITHRA K
kalinga Institute of Medical Sciences,Bhubaneswar
Outcome results
None listed